Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Steen, R. G. Articles by Mulhern, R. K. Search for Related Content PubMed PubMed Citation Articles by Steen, R. G. Articles by Mulhern, R. K.

American Journal of Neuroradiology 24:382-389, March 2003
© 2003 American Society of Neuroradiology

PEDIATRICS

Cognitive Impairment in Children with Hemoglobin SS Sickle Cell Disease: Relationship to MR Imaging Findings and Hematocrit

R. Grant Steen^a, Mark A. Miles^b, Kathleen J. Helton^a, Susan Strawn^c, Winfred Wang^c, Xiaoping Xiong^d and Raymond K. Mulhern^b

^a Departments of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, TN
^b Behavioral Medicine, St. Jude Children’s Research Hospital, Memphis, TN
^c Hematology, St. Jude Children’s Research Hospital, Memphis, TN
^d Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN

Address reprint requests to R. Grant Steen, Department of Diagnostic Imaging, St. Jude Children’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105

BACKGROUND AND PURPOSE: Children with hemoglobin SS sickle cell disease are known to suffer cognitive impairment if they have silent infarct, but recent evidence suggests that patients with hemoglobin SS sickle cell disease may be impaired even if they are free of infarction. We test a hypothesis that cognitive impairment in children with hemoglobin SS sickle cell disease is associated with low hematocrit and MR imaging abnormalities.

METHODS: A cohort of 49 patients was examined, all of whom had hemoglobin SS sickle cell disease but no history of clinical stroke. The Wechsler scales, which are standardized and age-adjusted, were used to assess cognitive function. Patients also underwent MR imaging examination of the brain, and hematocrit was measured in a subset of 45 patients. MR images were evaluated by at least two readers, and abnormal imaging findings were evaluated by at least three readers. Any lesion was sufficient to be classified as abnormal, with lesions defined to include lacunar infarction, encephalomalacia, or leukoencephalopathy. Hematocrit data were used if obtained within 3 months of psychometric testing and if there were no confounding events in the patients’ charts. Wechsler test scores were then evaluated in relation to imaging findings and hematocrit values.

RESULTS: Patients with imaging abnormalities had more cognitive impairment than did patients with normal imaging findings in verbal intelligence quotient (P < .02) and verbal comprehension (P < .01). Patients with low hematocrit had cognitive impairment shown by many performance measures, including full-scale intelligence quotient (P < .006), verbal comprehension (P < .006), and freedom from distractibility (P < .02). Multivariate analysis showed that MR imaging and hematocrit were independent predictors of full-scale intelligence quotient.

CONCLUSION: Focal brain injury, revealed by MR imaging, is associated with cognitive impairment, but our data suggest that diffuse brain injury may also contribute to impairment. These findings show that impairment is multifactorial and suggest that chronic brain hypoxia is part of the pathophysiology of sickle cell disease.

This article has been cited by other articles:

				J. Schatz, C. B. McClellan, E. S. Puffer, K. Johnson, and C. W. Roberts Neurodevelopmental Screening in Toddlers and Early Preschoolers With Sickle Cell Disease J Child Neurol, January 1, 2008; 23(1): 44 - 50. [Abstract] [PDF]

				J. J. Strouse, C. S. Cox, E. R. Melhem, H. Lu, M. A. Kraut, A. Razumovsky, K. Yohay, P. C. van Zijl, and J. F. Casella Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA) Blood, July 1, 2006; 108(1): 379 - 381. [Abstract] [Full Text] [PDF]

				R. G. Steen, T. Emudianughe, M. Hunte, J. Glass, S. Wu, X. Xiong, and W. E. Reddick Brain Volume in Pediatric Patients with Sickle Cell Disease: Evidence of Volumetric Growth Delay? AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 455 - 462. [Abstract] [Full Text] [PDF]

				R. G. Steen, C. Fineberg-Buchner, G. Hankins, L. Weiss, A. Prifitera, and R. K. Mulhern Cognitive Deficits in Children With Sickle Cell Disease J Child Neurol, February 1, 2005; 20(2): 102 - 107. [Abstract] [PDF]

				R. Grueneich, M. D. Ris, W. Ball, K. A. Kalinyak, R. Noll, K. Vannatta, and R. Wells Relationship of Structural Magnetic Resonance Imaging, Magnetic Resonance Perfusion, and Other Disease Factors to Neuropsychological Outcome in Sickle Cell Disease J. Pediatr. Psychol., March 1, 2004; 29(2): 83 - 92. [Abstract] [Full Text] [PDF]